SL-164
From Wikipedia, the free encyclopedia
Jump to: navigation, search
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
|
|
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C16H12Cl2N2O |
| Molar mass | 319.185 |
| 3D model (JSmol) | |
|
|
|
|
SL-164 is an analogue of methaqualone developed in the late 1960s by a team at Sumitomo.[1] SL-164 has similar sedative, hypnotic and anticonvulsant properties to the parent compound, but was never marketed for clinical use.[2]
References[edit]
- ^ US Patent 3651230 COMPOSITIONS AND METHODS FOR TRANQUILIZING WITH SUBSTITUTED 3-PHENYL-4-QUINAZOLINONE DERIVATIVES
- ^ Saito, C.; Sakai, S.; Yukawa, Y.; Yamamoto, H.; Takagi, H. (1969). "Pharmacological studies on 2-methyl-3(2'-methyl-4'-chlorophenyl)-5-chloro-4H)-quinazolinone (SL-164)". Arzneimittel-Forschung. 19 (12): 1945–1949. PMID 4985336.
| Alcohols | |
|---|---|
| Barbiturates |
|
| Benzodiazepines |
|
| Carbamates | |
| Flavonoids |
|
| Imidazoles | |
| Kava constituents | |
| Monoureides | |
| Neuroactive steroids |
|
| Nonbenzodiazepines |
|
| Phenols | |
| Piperidinediones | |
| Pyrazolopyridines | |
| Quinazolinones | |
| Volatiles/gases |
|
| Others/unsorted |
|
| This sedative-related article is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=SL-164&oldid=739424516"